Norway

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Nipocalimab in Moderate to Severe Sjogren's Disease

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Digital Long-term Follow-up of Patients With Coronary Artery Disease

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Exploring Medication Safety Practices in Anesthesia

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

A Long-Term Study of Navenibart in Participants With Hereditary Angioedema